Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: services market access outcomes strategy reimbursement dossiers hta submissions
… countries, and localities, with widening gaps in access, quality, and affordability of healthcare. But what … volatile and highly competitive global pharmaceutical market, demonstrating value to support launch of medicines … the value of integrated evidence generation. Related Services Health Economics Pharmacoepidemiology and Risk …
… . Our diverse background in clinical research, regulatory submissions, epidemiology studies, and drug, vaccine, and … projects or can set up long-term arrangements that allow access to specific experts on an ongoing basis. For example, …
… Medical Writing, Editing, and Design Services …
… these efforts, we have developed more than 25 evidence dossiers, contributed to hundreds of briefing documents, and …
… (HTA) Utility Measures: Not One-Size-Fits-All HTA Strategy and Submissions Are you up to date with HTA … utility weights. Where these weights are not available, outcomes may be valued using preferences that reflect the … Health Economic Evaluations to AIFA for pricing and reimbursement of medicines (Section E and Appendix 2)] (AIFA, …
JCA Development and Support We can be your expert partner for education and guidance throughout the whole development process including JCA impact on your product pipeline. We can help you with: JCA dossier and evidence refinement Post-submission support …
… Webinar: Navigating the Complex HTA Landscape for Medtech Success Share on: Wednesday, April … themselves asking questions such as, what products and services require HTA approval? Are apps, digital … Medtech is a rapidly expanding segment of the healthcare market with an estimated two million products available …
… understand drivers that could influence your product strategy. Chart reviews, separately or in combination with … impact models) Through our network of partners, we have access to patient charts in both developed and emerging … so you can make informed decisions related to study outcomes. For every study, we determine endpoints based on …
… our clients develop strategies in the infectious disease market and to develop and gain market access for products to treat infectious diseases and … studies Observational studies Patient-reported outcomes (PRO) studies Product value and access kits Stated …
… Services You must make critical decisions in today’s complex, … often, the knowledge needed to make good clinical, market access, and safety decisions isn’t readily available or …